← Open Payments lookup

JOANNA GULLION: Open Payments

NPI 1669142477 · LEXINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,853 in 90 payments from 25 companies in 2025. Trend: 2023 $22 · 2024 $0 · 2025 $1,853

Food & beverage: $1,853
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$332
ABBVIE INC.19$292
Alkermes, Inc.14$248
Bayer Healthcare Pharmaceuticals Inc.13$154
Vanda Pharmaceuticals Inc.2$151
GlaxoSmithKline, LLC.5$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Astellas Pharma US Inc3$68
Takeda Pharmaceuticals U.S.A., Inc.3$54
Boehringer Ingelheim Pharmaceuticals, Inc.2$45

Products named: BREZTRI, LYBALVI, VRAYLAR, Kerendia, FANAPT, TRELEGY ELLIPTA, CAPLYTA, Veozah.

Industry payments across IN — which companies pay providers there.